William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 150,000 shares at $91.01 ($13.6M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $13.6M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.36 | 149,300 | $13.5M | 99.5% |
| 2 | $91.01 | 700 | $64K | 0.5% |
| Total | $90.36 avg | 150,000 | $13.6M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |